Determinants of initial inhaled corticosteroid use in patients with GOLD A/B COPD: a retrospective study of UK general practice

Early-stage chronic lung disease: overuse of inhaled steroids in the UK Inhaled steroids are often prescribed to early-stage chronic lung disease patients in the UK despite guidelines to the contrary. Patients newly diagnosed with early-stage chronic obstructive pulmonary disease (COPD) should not b...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	James D. Chalmers, Abigail Tebboth, Alicia Gayle, Andrew Ternouth, Nick Ramscar
Formato:	article
Lenguaje:	EN
Publicado:	Nature Portfolio 2017
Materias:	Diseases of the respiratory system RC705-779
Acceso en línea:	https://doaj.org/article/5ffef56fd56b4f39828ae6080c7a9a1d
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:5ffef56fd56b4f39828ae6080c7a9a1d
record_format	dspace
spelling	oai:doaj.org-article:5ffef56fd56b4f39828ae6080c7a9a1d2021-12-02T12:30:23ZDeterminants of initial inhaled corticosteroid use in patients with GOLD A/B COPD: a retrospective study of UK general practice10.1038/s41533-017-0040-z2055-1010https://doaj.org/article/5ffef56fd56b4f39828ae6080c7a9a1d2017-06-01T00:00:00Zhttps://doi.org/10.1038/s41533-017-0040-zhttps://doaj.org/toc/2055-1010Early-stage chronic lung disease: overuse of inhaled steroids in the UK Inhaled steroids are often prescribed to early-stage chronic lung disease patients in the UK despite guidelines to the contrary. Patients newly diagnosed with early-stage chronic obstructive pulmonary disease (COPD) should not be prescribed inhaled corticosteroids (ICS), because they carry an increased risk of side effects such as pneumonia and osteoporosis. ICS should be reserved for patients with severe COPD and frequent exacerbations. James Chalmers at the Scottish Centre for Respiratory Research, Dundee, and co-workers examined prescribed medication data from the UK spanning 10 years, to determine key predictors of ICS prescription during early-stage COPD. Of 29,815 patients identified, an average of 63% were prescribed ICS upon diagnosis, regardless of disease severity. Younger patients were more likely to receive ICS, possibly due to co-morbidity with chronic asthma, and particular UK regions and medical practices prescribed ICS more readily than others.James D. ChalmersAbigail TebbothAlicia GayleAndrew TernouthNick RamscarNature PortfolioarticleDiseases of the respiratory systemRC705-779ENnpj Primary Care Respiratory Medicine, Vol 27, Iss 1, Pp 1-8 (2017)
institution	DOAJ
collection	DOAJ
language	EN
topic	Diseases of the respiratory system RC705-779
spellingShingle	Diseases of the respiratory system RC705-779 James D. Chalmers Abigail Tebboth Alicia Gayle Andrew Ternouth Nick Ramscar Determinants of initial inhaled corticosteroid use in patients with GOLD A/B COPD: a retrospective study of UK general practice
description	Early-stage chronic lung disease: overuse of inhaled steroids in the UK Inhaled steroids are often prescribed to early-stage chronic lung disease patients in the UK despite guidelines to the contrary. Patients newly diagnosed with early-stage chronic obstructive pulmonary disease (COPD) should not be prescribed inhaled corticosteroids (ICS), because they carry an increased risk of side effects such as pneumonia and osteoporosis. ICS should be reserved for patients with severe COPD and frequent exacerbations. James Chalmers at the Scottish Centre for Respiratory Research, Dundee, and co-workers examined prescribed medication data from the UK spanning 10 years, to determine key predictors of ICS prescription during early-stage COPD. Of 29,815 patients identified, an average of 63% were prescribed ICS upon diagnosis, regardless of disease severity. Younger patients were more likely to receive ICS, possibly due to co-morbidity with chronic asthma, and particular UK regions and medical practices prescribed ICS more readily than others.
format	article
author	James D. Chalmers Abigail Tebboth Alicia Gayle Andrew Ternouth Nick Ramscar
author_facet	James D. Chalmers Abigail Tebboth Alicia Gayle Andrew Ternouth Nick Ramscar
author_sort	James D. Chalmers
title	Determinants of initial inhaled corticosteroid use in patients with GOLD A/B COPD: a retrospective study of UK general practice
title_short	Determinants of initial inhaled corticosteroid use in patients with GOLD A/B COPD: a retrospective study of UK general practice
title_full	Determinants of initial inhaled corticosteroid use in patients with GOLD A/B COPD: a retrospective study of UK general practice
title_fullStr	Determinants of initial inhaled corticosteroid use in patients with GOLD A/B COPD: a retrospective study of UK general practice
title_full_unstemmed	Determinants of initial inhaled corticosteroid use in patients with GOLD A/B COPD: a retrospective study of UK general practice
title_sort	determinants of initial inhaled corticosteroid use in patients with gold a/b copd: a retrospective study of uk general practice
publisher	Nature Portfolio
publishDate	2017
url	https://doaj.org/article/5ffef56fd56b4f39828ae6080c7a9a1d
work_keys_str_mv	AT jamesdchalmers determinantsofinitialinhaledcorticosteroiduseinpatientswithgoldabcopdaretrospectivestudyofukgeneralpractice AT abigailtebboth determinantsofinitialinhaledcorticosteroiduseinpatientswithgoldabcopdaretrospectivestudyofukgeneralpractice AT aliciagayle determinantsofinitialinhaledcorticosteroiduseinpatientswithgoldabcopdaretrospectivestudyofukgeneralpractice AT andrewternouth determinantsofinitialinhaledcorticosteroiduseinpatientswithgoldabcopdaretrospectivestudyofukgeneralpractice AT nickramscar determinantsofinitialinhaledcorticosteroiduseinpatientswithgoldabcopdaretrospectivestudyofukgeneralpractice
_version_	1718394400484098048

Determinants of initial inhaled corticosteroid use in patients with GOLD A/B COPD: a retrospective study of UK general practice

Ejemplares similares